Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.

about

How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS.

P2860

Q47610137-E107D2D7-4D22-4B29-B4D9-248AF20C5192

P2860

Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.

Item

http://www.wikidata.org/entity/Q40075698

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Outcomes for Women with Minima ...... letely Excised at Core Biopsy.

@en

type

Item

label

Outcomes for Women with Minima ...... letely Excised at Core Biopsy.

@en

prefLabel

Outcomes for Women with Minima ...... letely Excised at Core Biopsy.

@en

P1476

Outcomes for Women with Minima ...... letely Excised at Core Biopsy.

@en

P2093

Andrea V Barrio

http://www.w3.org/2001/XMLSchema#string

Cristina Olcese

http://www.w3.org/2001/XMLSchema#string

Megan Miller

http://www.w3.org/2001/XMLSchema#string

Shirin Muhsen

http://www.w3.org/2001/XMLSchema#string

Sujata Patil

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study.

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.

Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?

P2888

s10434-017-6043-8

P31

scholarly article

P356

10.1245/S10434-017-6043-8

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly Van Zee

Monica Morrow

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091288415

http://www.w3.org/2001/XMLSchema#string

P698

28828599

http://www.w3.org/2001/XMLSchema#string

P921

biopsy

P932

5697712

http://www.w3.org/2001/XMLSchema#string

Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.

about

P2860

P2860

Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P50

P577

P6179

P698

P921

P932